Literature DB >> 14645307

Inhibition of SARS-associated coronavirus infection and replication by RNA interference.

Ming-Liang He, Bojian Zheng, Ying Peng, Joseph S M Peiris, Leo L M Poon, Kwok Y Yuen, Marie C M Lin, Hsiang-fu Kung, Yi Guan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14645307     DOI： 10.1001/jama.290.20.2665

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  55 in total

Review 1.  RNA interference and antiviral therapy.

Authors:  Yan Ma; Chu-Yan Chan; Ming-Liang He
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

2.  Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release.

Authors:  Wei Lu; Bo-Jian Zheng; Ke Xu; Wolfgang Schwarz; Lanying Du; Charlotte K L Wong; Jiadong Chen; Shuming Duan; Vincent Deubel; Bing Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

3.  Emerging Technologies for the Treatment of COVID-19.

Authors:  Hossein Aghamollaei; Rahim Sarvestani; Hamid Bakherad; Hamed Zare; Paul C Guest; Reza Ranjbar; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  A novel concept of human antiviral protection: It's all about RNA (Review).

Authors:  Tamara Aripova; Javdat Muratkhodjaev
Journal:  Biomed Rep       Date:  2022-02-18

5.  Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease.

Authors:  Christine L Wohlford-Lenane; David K Meyerholz; Stanley Perlman; Haixia Zhou; Dat Tran; Michael E Selsted; Paul B McCray
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

6.  Controllable inhibition of hepatitis B virus replication by a DR1-targeting short hairpin RNA (shRNA) expressed from a DOX-inducible lentiviral vector.

Authors:  Weiwei Wang; Hongquan Peng; Jiafu Li; Xiping Zhao; Fei Zhao; Kanghong Hu
Journal:  Virus Genes       Date:  2013-02-09       Impact factor: 2.332

7.  RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy.

Authors:  Rene Alvarez; Sayda Elbashir; Todd Borland; Ivanka Toudjarska; Philipp Hadwiger; Mathias John; Ingo Roehl; Svetlana Shulga Morskaya; Rick Martinello; Jeffrey Kahn; Mark Van Ranst; Ralph A Tripp; John P DeVincenzo; Rajendra Pandey; Martin Maier; Lubomir Nechev; Muthiah Manoharan; Victor Kotelianski; Rachel Meyers
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

Review 8.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

9.  Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation.

Authors:  Musa Khaitov; Alexandra Nikonova; Igor Shilovskiy; Ksenia Kozhikhova; Ilya Kofiadi; Lyudmila Vishnyakova; Alexander Nikolskii; Pia Gattinger; Valeria Kovchina; Ekaterina Barvinskaia; Kirill Yumashev; Valeriy Smirnov; Artem Maerle; Ivan Kozlov; Artem Shatilov; Anastasiia Timofeeva; Sergey Andreev; Olesya Koloskova; Nadezhda Kuznetsova; Daria Vasina; Maria Nikiforova; Sergei Rybalkin; Ilya Sergeev; Dmitriy Trofimov; Alexander Martynov; Igor Berzin; Vladimir Gushchin; Aleksey Kovalchuk; Sergei Borisevich; Rudolf Valenta; Rakhim Khaitov; Veronica Skvortsova
Journal:  Allergy       Date:  2021-05-10       Impact factor: 14.710

Review 10.  Molecular mechanisms of severe acute respiratory syndrome (SARS).

Authors:  David A Groneberg; Rolf Hilgenfeld; Peter Zabel
Journal:  Respir Res       Date:  2005-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.